?

Asghar Najjam

Chief Financial Officer
Sorrento Therapeutics, Inc.
US, San Diego [HQ]
CIK 1822126

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Compensation

SRNE Compensations